City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
July 11, 2017 | City of Hope
City of Hope’s Diabetes & Metabolism Research Institute is committed to developing a cure for type 1 diabetes within six years, fueled by a $50 million funding program led by the Wanek family.
June 27, 2017 | Samantha Bonar
Bart O. Roep, Ph.D., has dedicated his life to the search for a cure for type 1 diabetes. And he thinks he is on the brink. Roep, an internationally renowned immunologist who joined City of Hope last year from the Netherlands’ Leiden University Medical Center, was recently named the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes. He believes that this endowment and a $50 million funding project led by the Wanek family will be key in stopping the disease.
June 6, 2017 | Letisia Marquez
City of Hope’s rich history is filled with stories of celebrated researchers who helped shape the course of modern medicine. Yoko Fujita-Yamaguchi, Ph.D., professor emeritus in the Diabetes & Metabolism Research Institute at City of Hope, has written a book in Japanese that delves into the contributions of Japanese-American scientists at City of Hope.
April 24, 2017 | Michael Easterling
At City of Hope, Ella Fitzgerald's legacy lives on with areas on campus honoring her and diabetes research in her name supported by the Ella Fitzgerald Charitable Foundation.
April 24, 2017 | Denise Heady
What started as an unplanned lunch date has turned into a potential breakthrough in the treatment of gliomas – a fast-growing, and often deadly type of brain tumor.
April 4, 2017 | Stephanie Smith
City of Hope is dedicating every day in April, National Minority Health Month, to beginning to examine important issues of disparity in health care.
March 1, 2017 | Katie Neith
A recent clinical trial monitored by City of Hope’s Bart Roep, Ph.D., showed promising results for a possible cure of type 1 diabetes (T1D). Although the study involved risky stem cell transplant procedures, it identified new paths for personalized therapies of T1D.
February 27, 2017 | Katie Neith
For decades, scientists believed that the root cause of type 1 diabetes (T1D) was the immune system mistakenly identifying insulin secreting beta cells as a potential danger and, in turn, destroying them. Now, a study led by City of Hope’s Bart Roep turns that idea on its head.